CIE Advisory Board Profile
James H. Thompson
James H. (Jim) Thompson has more than 25 years of international strategy consulting experience, primarily serving the pharmaceutical and biotechnology industries. His areas of expertise are business and commercialization planning, market research and analysis, and business development, where he helps companies identify and evaluate growth opportunities and implement revenue generating activities. Client engagements have included international product launches, acquisition and licensing analyses, development of marketing and strategic plans, competitive assessments, pricing and reimbursement analyses, and market forecasts.
Jim is currently a Principal with Aquest Consulting, a biopharmaceutical management consulting firm, serving clients throughout the United States. Prior to co-founding Aquest Consulting, Jim was a Partner with Front Line Strategic Consulting, where he led international client engagements and business development activities. Jim was instrumental in Front Line’s rapid international growth and its ultimate sale to Navigant Consulting in late 2003. After the acquisition of Front Line, Jim served as a Director with Navigant, where he was responsible for business development and expanding the Life Science Practice’s east coast presence. Jim began his consulting career as a Senior Industry Analyst with SRI International’s Business Intelligence Center and later with SRI Consulting’s Health Industries Practice as a Senior Consultant.
Jim earned his MBA from U.C. Berkeley and a BA in molecular biology/minor in chemistry from San Jose State University. He has served as a mentor and lecturer for the CAPE program since 2010.